10/27/2025Hengrui's TROP-2 ADC SHR-A1921 Shows Promising Activity in First-in-Hu...

10/27/2025AstraZeneca Unveils Three Major Initiatives in China

10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...

10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...

10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...

10/27/2025CytoCares Raises CNY 68M in Series A++ Round Led by Tellgen

10/27/2025Taiho Secures Japan Rights to Haihe’s PI3Kα Inhibitor Risovalisib

10/27/2025Kite Strikes $1.5B Cell Therapy Deal With Pregene amid Industry Pullba...

10/25/2025Recent Executive Moves

10/24/2025China NMPA Publishes 97th Batch of Reference Formulations for Generic...

10/24/2025Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...

10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...

10/24/2025Biokin Passes HKEX Hearing, Poised for Hong Kong Listing

10/24/2025Terns Halts Development of TERN-601 After Phase 2 Results

10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF

10/24/2025Starna Thera Raises $44M in Series B to Advance RNA-Based Therapies

10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139

10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...

10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...

10/22/2025China's Aging Population to Drive Trillion-Dollar Healthcare Boom, UBS...

10/22/2025Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...

10/22/2025Innovent and Takeda Ink $11.4B Oncology Alliance

10/21/2025Henlius' PD-L1 ADC HLX43 Receives Orphan Drug Designation in the U.S.

10/21/2025CSPC's JSKN003 Granted Breakthru Therapy Designation in China

10/21/2025Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/21/2025Riltide Completes Seed Financing to Advance AI-Driven Autoimmune Thera...

10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA

10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...

10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...

10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC

Page:1/58 Total number of articles:1732: [First][<<] [1] [2] [3] [4] [5] [>>] [End]